抗肿瘤药物临床超常用药分析(5)
[24] MOREAU P，PYLYPENKO H，GROSICKI S，et al. Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma：a randomized，phase 3，non-inferiority study[J]. Lancet Oncol，2011，12(5)：431-440.[25] CHEN DW，SONG XY，SHI F，et al. Greater efficacy of intracavitary infusion of bevacizumab compared to traditional local treatments for patients with malignant cavity serous effusion[J]. Oncotarget ......
您现在查看是摘要页，全文长 2640 字符。